Answers are grounded in this paper and cite their sources.
Background Prospective studies of CAR T-cell therapy have described changes in patient-reported outcomes, but these are rarely examined alongside supportive care preferences and patients’ own accounts. We examined these components together across the treatment course. Methods This prospective single-center study included adults scheduled for CAR T-cell therapy at a German tertiary hospital. Of 52 patients in the screening/recruitment log, 32 who completed at least three of four assessments formed the longitudinal cohort. Assessments occurred before treatment (T0), during post-infusion hospitalization (T1), at or around discharge (T2), and seven to eight weeks after discharge (T3). Standardized measures assessed quality of life, anxiety/depression, loneliness, fear of progression, somatic symptoms, and social support. Unadjusted generalized estimating equations examined longitudinal change; supportive care items were summarized descriptively and open-ended responses analyzed thematically. Results The cohort included 17 male and 15 female participants; median age was 61.0 years (IQR 53.0-65.5), and 23/32 (71.9%) had multiple myeloma. Global health status/quality of life showed an overall time effect (p = 0.001), with the lowest mean at T2 and recovery by T3. Physical functioning was nominally lower at T2 (β = -14.450, p = 0.046); fatigue was nominally higher at T1 and T2 (β = 11.990, p = 0.015; β = 15.574, p = 0.008), and the QLQ-C30 summary score lower at T1 and T2 (β = -7.772, p = 0.006; β = -6.954, p = 0.035). Loneliness was nominally higher at T1 (β = 0.795, p = 0.009), whereas PHQ-4 scores changed little. Across timepoints, 60.0% to 70.0% considered post-discharge psycho-oncological support useful and 66.7% to 79.3% considered peer contact useful. Five themes concerned treatment uncertainty, physical decline, multidimensional support needs, accessible individualized digital support, and incomplete treatment understanding. Conclusions Patient-reported physical and functional burden was greatest during hospitalization and around discharge and improved by seven to eight weeks after discharge. Brief anxiety/depression scores captured only part of participants’ support needs. The findings can inform co-design and prospective evaluation of longitudinal supportive care approaches without establishing intervention effectiveness.
No takes yet. Share an insight, caveat, or question.
Fleischer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: